In HPV-positive tumors, PD-L1+ tumor cells were enriched at the tumor-immune interface, and ICOS+ CD4 T- cells were enriched in the tumor core, suggesting enhanced tumor-reactive T-cell activity. The gene discussed is CD4; the disease is neoplasm.